Abbott Vascular, a division of Abbott, is one of the world's leading vascular care businesses. Abbott Vascular is uniquely focused on advancing the treatment of vascular disease and improving patient care by combining the latest medical device innovations with world-class pharmaceuticals, investing in research and development, and advancing medicine through training and education. Headquartered in Northern California, Abbott Vascular offers a comprehensive portfolio of vessel closure, endovascular and coronary products that are recognized internationally for their safety, effectiveness and ease of use in treating patients with vascular disease.
Bard Peripheral Vascular provides a comprehensive range of surgical and endovascular products for use in the treatment of peripheral vascular disease. An intensive new product development programme has ensured the Bard portfolio remains one of the most exciting and comprehensive in the medical devices industry.
Cook Medical is the world’s largest privately held designer and manufacturer of minimally invasive medical device technology. A leader in the diagnosis and treatment of vascular disease, Cook continues a tradition of innovative thinking and development with comprehensive procedural offerings in EVAR, leg therapies, pulmonary embolism prevention and embolization. www.cookmedical.com
Cordis – Your partner in the Cath Lab.
For more than 50-years, Cordis has pioneered less invasive treatments for cardiovascular disease. A global leader in developing and marketing innovative devices for circulatory disease management, it is committed to delivering the right combination of products, services and evidence to help optimize patient outcomes. Its service offering to physicians includes a comprehensive educational programme under the banner of CCVI (Cordis Cardiac & Vascular Institute - go to: ccvi-online.com to find out more).
The company has a strong commitment to evidence-based medicine and a record of leadership, funding major trials that have significantly improved circulatory disease management across all indications. Cordis has led the way in pioneering, developing and establishing intravascular stenting as an effective treatment option for patients with circulatory disease.
?The Gore Medical Products Division has provided creative therapeutic solutions to complex medical problems for 35 years. More than 25 million innovative Gore Medical Devices have been implanted, saving and improving the quality of lives worldwide. The product family includes vascular grafts, endovascular and interventional devices, surgical materials, and sutures.
?The Powerlink stent graft is the only endovascular system for the treatment of abdominal aortic aneurysms that uses anatomical fixation to inhibit migration. Its new, low-profile IntuiTrak Delivery System has an integrated 19Fr introducer sheath featuring enhanced flexibility, advanced haemostasis control, and hydrophilic coating to facilitate smooth delivery.
?MAQUET Cardiovascular combines the expertise with trends in cardiovascular surgery to develop new and innovative products. The MAQUET Cardiovascular portfolio offers state-of-the-art products and services for the optimal treatment of patients. MAQUET maintains a singular focus: to be the first choice in the operating room.
Medtronic is the global leader in medical technology- alleviating pain, restoring health, and extending life for people with chronic conditions around the world. Medtronic develops and manufactures a wide range of products and therapies with emphasis on providing a complete continuum of care to diagnose, prevent and monitor chronic conditions. Each year, Medtronic therapies help more than seven million people.
?Terumo is a Japanese company founded in 1921 by a group of physicians, led by Shibasaburo Kitasato. Pioneering the development of the hydrophilic concept for high performance minimal invasive medical devices, Terumo offers to physicians a wide range of products for interventional procedures including stents, percutaneous transluminal coronary angioplasty/percutaneous transluminal angioplasty balloons, embolic coils, diagnostic catheters, microcatheters, guidewires and accessories.
?Vascutek, a Terumo company, is one of the world leaders in the design and production of vascular grafts and cardiovascular patches. Vascutek offers state-of-the-art Anaconda with the BluGlide superhydrophilic introducer sheath, the next generation of abdominal aortic aneurysm stent graft systems. Combining ePTFE, textile and bioresorbable sealant expertise, with a dedication to focused research, Vascutek also offers an extensive range of sealed and unsealed ePTFE and polyester prostheses.
